{
    "code": "02023013",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023013",
    "time": "2020-06-26 05:14:02",
    "許可證字號": "衛署藥輸字第023013號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/10\/05",
    "發證日期": "89\/10\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202301303",
    "中文品名": "安得復加強錠",
    "英文品名": "ARFEN PLUS TABS",
    "適應症": "鎮痛、解熱。",
    "劑型": "110錠劑",
    "包裝": "鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ACETAMINOPHEN (EQ TO PARACETAMOL), CAFFEINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1800901100  雙正貿易股份有限公司",
    "申請商地址": "台北市忠孝東路五段５０８號６樓之３",
    "主製造廠": [
        {
            "製造廠名稱": "FCY0009000  MEDOCHEMIE LTD.",
            "製造廠廠址": "1-10 CONSTANTINOUPOLEOS STREET, 3011 LIMASSOL, CYPRUS",
            "製造廠公司地址": "",
            "製造廠國別": "CYPRUS",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808000100",
            "成分名稱": "ACETAMINOPHEN (EQ TO PARACETAMOL)",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000400",
            "成分名稱": "CAFFEINE",
            "含量描述": "(EP)",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "ARFEN,PLUS",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02023013.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023013&Seq=436&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Arfen Plus仿單2019Dec-109-04-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023013&Seq=005&Type=9"
        },
        {
            "title": "Arfen Plus藥品外觀2019Dec-109-04-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023013&Seq=009&Type=8"
        },
        {
            "title": "Arfen Plus外盒2019Dec-109-04-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023013&Seq=008&Type=8"
        },
        {
            "title": "020230130005___20100923.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023013&Seq=005&Type=8"
        }
    ]
}